| NCT ID | NCT03923101 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universität des Saarlandes |
| Condition | Keratoconus |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2011-01-01 |
| Primary Completion | 2036-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2011-01-01 with a primary completion date of 2036-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Aim of this study is to conduct longitudinal and cross-sectional analyses about the corneal ectatic disease Keratoconus based on data obtained from Keratoconus patients in the Homburg Keratoconus Center (HKC). The Homburg Keratoconus Center (HKC) was founded in 2010 and, up to now, comprises more than 3,000 Keratoconus patients. Topographic, tomographic and biomechanic characteristics of the disease are being analyzed with the intention to elucidate how the disease begins and develops during lifetime.
Eligibility Criteria
Inclusion Criteria: * All Keratoconus patients presenting in the department of ophthalmology, Saarland University Medical Center, Homburg, Saarland, Germany. Exclusion Criteria: * Patients without Keratoconus.
Frequently Asked Questions
Who can join the NCT03923101 clinical trial?
This trial is open to participants of all sexes, studying Keratoconus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03923101 currently recruiting?
Yes, NCT03923101 is actively recruiting participants. Visit ClinicalTrials.gov or contact Universität des Saarlandes to inquire about joining.
Where is the NCT03923101 trial being conducted?
This trial is being conducted at Homburg, Germany.
Who is sponsoring the NCT03923101 clinical trial?
NCT03923101 is sponsored by Universität des Saarlandes. The trial plans to enroll 5,000 participants.